Abstract
This study assesses changes in hospitals’ capital assets after private equity acquisition.
Private equity firms spent $505 billion on health care acquisitions between 2018 and 2023.1 Financial infusions may augment resources for care.2,3 However, firms have sometimes sold acquired hospitals’ land and buildings, repaying investors with proceeds and burdening hospitals with rent payments for facilities they once owned.3
We assessed changes in hospitals’ capital assets after private equity acquisition.
Methods
We identified private equity–acquired US acute care hospitals and their acquisition years with the Private Equity Stakeholder Project Private Equity Hospital Tracker (eAppendix in Supplement 1), which we verified and augmented using a prior study,4 press reports, and Medicare cost reports. We excluded HCA Healthcare–owned hospitals, which prior studies suggest are atypical of private equity acquisitions.5
Using 2006 to 2021 Medicare cost reports, we assessed hospitals’ total capital assets (summing land, buildings, equipment, and health information technology), year last acquired, share of Medicaid inpatient discharges, rurality, teaching status, number of beds, and region. We excluded acquired hospitals with total assets outside the 95th and fifth percentiles during acquisition year (to minimize distortions from data-entry errors) and those acquired after 2019 (to ensure at least 2 years of postacquisition data).
We matched acquired hospitals to 10 nonacquired controls, using exact matching on year, region, and bed size category and nearest-neighbor matching on total capital assets during acquisition year (eAppendix in Supplement 1).4,6 We analyzed assets of acquired and control hospitals in 2 years before and after acquisition, using a difference-in-differences event-study specification. We used a linear mixed-effects model with year fixed effects and a random intercept term for each matched group to adjust for within-group correlation. The interaction term between time and acquisition status provides the difference-in-differences estimate. To facilitate verification of the parallel trends assumption and assess whether the 2-year postacquisition trends persisted, we also plotted and analyzed mean asset values of acquired and control hospitals for 10 years before and 5 years after acquisition.
Analyses were performed with R version 4.2.3 (R Foundation for Statistical Computing), with 2-tailed P < .05 statistically significant.
Results
Of 197 acquired hospitals, 156 met inclusion criteria and were matched with 1560 controls. Hospitals were acquired between 2010 and 2019, most commonly in 2018 (n = 67) and 2017 (n = 38). Acquired hospitals were mostly in the South (n = 87, 55.8%) and had 50 to 149 beds (n = 70, 44.9%). Compared with controls, fewer acquired hospitals were critical access (7.7% of acquired, 16.1% of controls; P = .008) or rural (0.6% of acquired, 4.2% of controls; P = .05). There were no significant differences in teaching hospital status (21.8% of acquired, 20.1% of controls; P = .68) or Medicaid share of discharges (11% for acquired, 10.3% for controls; P = .39).
Assets during acquisition year were $91 316 399 for acquired hospitals and $96 450 259 for controls (P = .49) (Figure). In the 2 years after acquisition, assets decreased by a mean (SD) of 15.0% (78.2%) for acquired hospitals and increased by 9.2% (36.3%) for controls, a 24.2% difference (95% CI, 11.6%-36.8%; P < .001), or from a mean (SD) of $87 705 471 ($76 823 078) in the 2 years before acquisition to $69 615 470 ($72 146 133) after (compared with $95 086 116 [$91 236 379] before and $102 495 629 [$100 050 927] after for controls, a difference-in-differences estimate of −$27 954 180; 95% CI, −$21 992 157 to −$33 916 202) (Table). After 2 years, 61.0% of acquired hospitals had reduced capital assets vs 15.5% of controls. Visual inspection of the graph of trends in assets in the 10 years before the acquisition year supported the parallel trends assumption, and data for 5 years after acquisition showed trends persisted and widened.
Figure. Mean Capital Assets of Private Equity–Acquired and Control Hospitals Before and After Acquisition (Year 0).
Curves show the mean capital assets of 156 hospitals acquired by private equity firms and 1560 matched control hospitals. Year 0 (dotted vertical line) represents the year of acquisition for each private equity hospital or that same calendar year for its 10 matched control hospitals.
Table. Changes in Hospital Total Capital Assets After Private Equity Acquisition Compared With Matched Controlsa.
| Total capital assets, $ | Mean difference, $b | DID estimate of difference (95% CI), $c | P value | ||
|---|---|---|---|---|---|
| Acquired hospitals | Matched controls | ||||
| Before acquisitiond | 87 705 471 | 95 086 116 | NA | NA | NA |
| After acquisitione | 69 615 470 | 102 495 629 | NA | NA | NA |
| Change | −18 090 001 | 7 409 513 | −25 499 514 | −27 954 180 (−21 992 157 to −33 916 202) | <.001 |
Abbreviations: DID, difference-in-differences; NA, not applicable.
Hospitals acquired by private equity were matched to 10 control hospitals (eAppendix in Supplement 1).
Mean difference shows the unadjusted difference between acquired hospitals and control hospitals in the 2 years before acquisition vs 2 years after acquisition.
The DID estimate includes year fixed effects and a random intercept term for each matched group to adjust for within-group correlation.
Before-acquisition figures are the mean of the 2 preacquisition years.
After-acquisition figures are the mean of the 2 postacquisition years. The text provides mean figures for capital assets during the acquisition year.
Discussion
After private equity acquisition, hospital assets decreased by 24% relative to that of controls during 2 years.
Study limitations included the small sample of acquired hospitals despite use of multiple sources to identify acquisitions. Private equity acquisitions are not required to be publicly reported, hampering identification. Closed hospitals were not included, possibly causing underestimation of capital losses. Many private equity acquisitions occurred recently and the drop-off in data at 4 and 5 years after acquisition precluded analysis of longer-term trends. Medicare cost reports may include errors, although they are audited. Many hospitals did not report components of total capital assets.
Private equity acquisitions appear to have depleted, rather than augmented, hospital assets. Although funds from asset drawdowns might be redeployed to enhance care or efficiency, previous studies suggest such effects may not occur.4 Financial outcome of private equity hospital acquisitions and effects on patient care require further study.
Section Editors: Kristin Walter, MD, and Jody W. Zylke, MD, Deputy Editors; Karen Lasser, MD, MPH, Senior Editor.
eAppendix. Methods
Data Sharing Statement
References
- 1.Jain N, Murphy K, Podpolny D, Klingan FR, Kapur V, Boulton A. Healthcare private equity market 2023: year in review and outlook. Bain & Company. Published January 3, 2024. Accessed March 11, 2024. https://www.bain.com/insights/year-in-review-global-healthcare-private-equity-report-2024/
- 2.Frances C. Private equity investment in health care. JAMA. 2019;322(5):468. doi: 10.1001/jama.2019.7844 [DOI] [PubMed] [Google Scholar]
- 3.Appelbaum E, Batt R. Private equity buyouts in healthcare: who wins, who loses? Institute for New Economic Thinking. Accessed February 17, 2024. https://www.ineteconomics.org/research/research-papers/private-equity-buyouts-in-healthcare-who-wins-who-loses
- 4.Kannan S, Bruch JD, Song Z. Changes in hospital adverse events and patient outcomes associated with private equity acquisition. JAMA. 2023;330(24):2365-2375. doi: 10.1001/jama.2023.23147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bruch JD, Gondi S, Song Z. Changes in hospital income, use, and quality associated with private equity acquisition. JAMA Intern Med. 2020;180(11):1428-1435. doi: 10.1001/jamainternmed.2020.3552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Joynt KE, Orav EJ, Jha AK. Association between hospital conversions to for-profit status and clinical and economic outcomes. JAMA. 2014;312(16):1644-1652. doi: 10.1001/jama.2014.13336 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
eAppendix. Methods
Data Sharing Statement

